HuGE Literature Finder
Records 1-30
|
Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey.
BMC cancer 2020 Oct 20 (1): 994. Sun Peng, Li Yue, Chao Xue, Li Jibin, Luo Rongzhen, Li Mei, He Jieh |
|
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Breast cancer research : BCR 2020 Oct 22 (1): 107. Fumagalli Caterina, Ranghiero Alberto, Gandini Sara, Corso Federica, Taormina Sergio, De Camilli Elisa, Rappa Alessandra, Vacirca Davide, Viale Giuseppe, Guerini-Rocco Elena, Barberis Massi |
|
Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients.
European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
|
Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Cancer reports (Hoboken, N.J.) 2020 Jul e1267. Naderi A |
|
Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
Cancer biomarkers : section A of Disease markers 2020 Feb . Geng Hua, Li Shixiong, Guo Yixian, Yan Fang, Han Yuebin, Xu Meilin, Cui Yanz |
|
Germline cancer predisposition variants and pediatric glioma: a population-based study in California.
Neuro-oncology 2020 Jan . Muskens Ivo S, de Smith Adam J, Zhang Chenan, Hansen Helen M, Morimoto Libby, Metayer Catherine, Ma Xiaomei, Walsh Kyle M, Wiemels Joseph |
|
Characterizations of Gene Alterations in Melanoma Patients from Chinese Population.
BioMed research international 2020 2020 6096814. Luo Yi, Zhang Zhenzhen, Liu Jianfan, Li Linqing, Xu Xuezheng, Yao Xinyu, Dai Zixun, Wang Xin, Yang Shuo, Wu Hongwei, Bu Jie, Wu Yuan, Xiang Tianmin, Li Xian |
|
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling.
Molecular genetics & genomic medicine 2019 Dec e1079. Chen Zhanhong, Sun Tian, Yang Ziyan, Zheng Yabing, Yu Ruoying, Wu Xue, Yan Junrong, Shao Yang W, Shao Xiying, Cao Wenming, Wang Xiaoj |
|
Genomic Underpinnings of Tumor Behavior in
American journal of respiratory and critical care medicine 2019 Nov . Qian Jun, Zhao Shilin, Zou Yong, Rahman S M Jamshedur, Senosain Maria-Fernanda, Stricker Thomas, Chen Heidi, Powell Charles A, Borczuk Alain C, Massion Pierre |
|
TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer.
Clinical genitourinary cancer 2019 Nov . Chapman Lynne, Ledet Elisa M, Barata Pedro C, Cotogno Patrick, Manogue Charlotte, Moses Marcus, Christensen Bryce R, Steinwald Peter, Ranasinghe Lahiru, Layton Jodi L, Lewis Brian E, Sartor Oliv |
|
Mutation profiling of cancer drivers in Brazilian colorectal cancer.
Scientific reports 2019 Sep 9 (1): 13687. Dos Santos Wellington, Sobanski Thais, de Carvalho Ana Carolina, Evangelista Adriane Feijó, Matsushita Marcus, Berardinelli Gustavo Nóriz, de Oliveira Marco Antonio, Reis Rui Manuel, Guimarães Denise Peixo |
|
Co-occurring genetic alterations predict distant metastasis and poor efficacy of first-line EGFR-TKIs in EGFR-mutant NSCLC.
Journal of cancer research and clinical oncology 2019 Aug . Deng Li-Li, Gao Ge, Deng Hong-Bin, Wang Feng, Wang Zhi-Hui, Yang |
|
NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas.
Cancer medicine 2019 Jun . Tlemsani Camille, Pécuchet Nicolas, Gruber Aurelia, Laurendeau Ingrid, Danel Claire, Riquet Marc, Le Pimpec-Barthes Françoise, Fabre Elizabeth, Mansuet-Lupo Audrey, Damotte Diane, Alifano Marco, Luscan Armelle, Rousseau Benoit, Vidaud Dominique, Varin Jennifer, Parfait Beatrice, Bieche Ivan, Leroy Karen, Laurent-Puig Pierre, Terris Benoit, Blons Helene, Vidaud Michel, Pasmant Er |
|
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
|
Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
Human genomics 2019 Jan 13 (1): 4. Yi Dandan, Xu Lei, Luo Jiaqi, You Xiaobin, Huang Tao, Zi Yi, Li Xiaoting, Wang Ru, Zhong Zaixuan, Tang Xiaoqiao, Li Ang, Shi Yujian, Rao Jianmei, Zhang Yifen, Sang Jianfe |
|
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Journal of hematology & oncology 2018 Oct 11 (1): 124. Liang Xu, Briaux Adrien, Becette Véronique, Benoist Camille, Boulai Anais, Chemlali Walid, Schnitzler Anne, Baulande Sylvain, Rivera Sofia, Mouret-Reynier Marie-Ange, Bouvet Laurence Venat, De La Motte Rouge Thibaut, Lemonnier Jérôme, Lerebours Florence, Callens Céli |
|
Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.
BMC cancer 2018 Oct 18 (1): 1054. Iida Yuuki, Salomon Matthew P, Hata Keisuke, Tran Kevin, Ohe Shuichi, Griffiths Chester F, Hsu Sandy C, Nelson Nellie, Hoon Dave S |
|
The prognostic effects of somatic mutations in ER-positive breast cancer.
Nature communications 2018 Sep 9 (1): 3476. Griffith Obi L, Spies Nicholas C, Anurag Meenakshi, Griffith Malachi, Luo Jingqin, Tu Dongsheng, Yeo Belinda, Kunisaki Jason, Miller Christopher A, Krysiak Kilannin, Hundal Jasreet, Ainscough Benjamin J, Skidmore Zachary L, Campbell Katie, Kumar Runjun, Fronick Catrina, Cook Lisa, Snider Jacqueline E, Davies Sherri, Kavuri Shyam M, Chang Eric C, Magrini Vincent, Larson David E, Fulton Robert S, Liu Shuzhen, Leung Samuel, Voduc David, Bose Ron, Dowsett Mitch, Wilson Richard K, Nielsen Torsten O, Mardis Elaine R, Ellis Matthew |
Identification of nine new susceptibility loci for endometrial cancer.
Nature communications 2018 Aug 9 (1): 3166. O'Mara Tracy A, Glubb Dylan M, Amant Frederic, Annibali Daniela, Ashton Katie, Attia John, Auer Paul L, Beckmann Matthias W, Black Amanda, Bolla Manjeet K, Brauch Hiltrud, Brenner Hermann, Brinton Louise, Buchanan Daniel D, Burwinkel Barbara, Chang-Claude Jenny, Chanock Stephen J, Chen Chu, Chen Maxine M, Cheng Timothy H T, Clarke Christine L, Clendenning Mark, Cook Linda S, Couch Fergus J, Cox Angela, Crous-Bous Marta, Czene Kamila, Day Felix, Dennis Joe, Depreeuw Jeroen, Doherty Jennifer Anne, Dörk Thilo, Dowdy Sean C, Dürst Matthias, Ekici Arif B, Fasching Peter A, Fridley Brooke L, Friedenreich Christine M, Fritschi Lin, Fung Jenny, García-Closas Montserrat, Gaudet Mia M, Giles Graham G, Goode Ellen L, Gorman Maggie, Haiman Christopher A, Hall Per, Hankison Susan E, Healey Catherine S, Hein Alexander, Hillemanns Peter, Hodgson Shirley, Hoivik Erling A, Holliday Elizabeth G, Hopper John L, Hunter David J, Jones Angela, Krakstad Camilla, Kristensen Vessela N, Lambrechts Diether, Marchand Loic Le, Liang Xiaolin, Lindblom Annika, Lissowska Jolanta, Long Jirong, Lu Lingeng, Magliocco Anthony M, Martin Lynn, McEvoy Mark, Meindl Alfons, Michailidou Kyriaki, Milne Roger L, Mints Miriam, Montgomery Grant W, Nassir Rami, Olsson Håkan, Orlow Irene, Otton Geoffrey, Palles Claire, Perry John R B, Peto Julian, Pooler Loreall, Prescott Jennifer, Proietto Tony, Rebbeck Timothy R, Risch Harvey A, Rogers Peter A W, Rübner Matthias, Runnebaum Ingo, Sacerdote Carlotta, Sarto Gloria E, Schumacher Fredrick, Scott Rodney J, Setiawan V Wendy, Shah Mitul, Sheng Xin, Shu Xiao-Ou, Southey Melissa C, Swerdlow Anthony J, Tham Emma, Trovik Jone, Turman Constance, Tyrer Jonathan P, Vachon Celine, VanDen Berg David, Vanderstichele Adriaan, Wang Zhaoming, Webb Penelope M, Wentzensen Nicolas, Werner Henrica M J, Winham Stacey J, Wolk Alicja, Xia Lucy, Xiang Yong-Bing, Yang Hannah P, Yu Herbert, Zheng Wei, Pharoah Paul D P, Dunning Alison M, Kraft Peter, De Vivo Immaculata, Tomlinson Ian, Easton Douglas F, Spurdle Amanda B, Thompson Deborah |
|
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.
Cancer cell 2018 Aug 34 (2): 242-255.e5. Gopal Raj K, Kübler Kirsten, Calvo Sarah E, Polak Paz, Livitz Dimitri, Rosebrock Daniel, Sadow Peter M, Campbell Braidie, Donovan Samuel E, Amin Salma, Gigliotti Benjamin J, Grabarek Zenon, Hess Julian M, Stewart Chip, Braunstein Lior Z, Arndt Peter F, Mordecai Scott, Shih Angela R, Chaves Frances, Zhan Tiannan, Lubitz Carrie C, Kim Jiwoong, Iafrate A John, Wirth Lori, Parangi Sareh, Leshchiner Ignaty, Daniels Gilbert H, Mootha Vamsi K, Dias-Santagata Dora, Getz Gad, McFadden David |
|
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
Breast cancer research and treatment 2018 Jun . Yap Yoon-Sim, Munusamy Prabhakaran, Lim Cindy, Chan Claire H T, Prawira Aldo, Loke Sau-Yeen, Lim Swee-Ho, Ong Kong-Wee, Yong Wei-Sean, Ng Sarah B H, Tan Iain B H, Callen David F, Lim Jeffrey C T, Thike Aye-Aye, Tan Puay-Hoon, Lee Ann S |
|
The genetic landscape of ganglioglioma.
Acta neuropathologica communications 2018 Jun 6 (1): 47. Pekmezci Melike, Villanueva-Meyer Javier E, Goode Benjamin, Van Ziffle Jessica, Onodera Courtney, Grenert James P, Bastian Boris C, Chamyan Gabriel, Maher Ossama M, Khatib Ziad, Kleinschmidt-DeMasters Bette K, Samuel David, Mueller Sabine, Banerjee Anuradha, Clarke Jennifer L, Cooney Tabitha, Torkildson Joseph, Gupta Nalin, Theodosopoulos Philip, Chang Edward F, Berger Mitchel, Bollen Andrew W, Perry Arie, Tihan Tarik, Solomon David |
|
DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
International journal of cancer 2018 Feb . Wu Shenshen, Meng Qingtao, Zhang Chengcheng, Sun Hao, Lu Runze, Gao Na, Yang Hongbao, Li Xiaobo, Aschner Michael, Chen R |
|
Next-generation panel sequencing identifies
European journal of endocrinology 2018 Feb 178 (2): K1-K9. Gieldon Laura, Masjkur Jimmy Rusdian, Richter Susan, Därr Roland, Lahera Marcos, Aust Daniela, Zeugner Silke, Rump Andreas, Hackmann Karl, Tzschach Andreas, Januszewicz Andrzej, Prejbisz Aleksander, Eisenhofer Graeme, Schrock Evelin, Robledo Mercedes, Klink Barba |
|
Racial Disparities in the Molecular Landscape of Cancer.
Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
|
SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.
BMC cancer 2018 04 18 (1): 479. Mei Zhu, Shao Yang W, Lin Peinan, Cai Xiaomin, Wang Biao, Ding Yan, Ma Xiangyuan, Wu Xue, Xia Yewei, Zhu Dongqin, Shu Yongqian, Fu Zan, Gu Yanho |
|
A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
Cancer 2017 Nov . Tricoli James V, Boardman Lisa A, Patidar Rajesh, Sindiri Sivasish, Jang Jin S, Walsh William D, McGregor Paul M, Camalier Corinne E, Mehaffey Michele G, Furman Wayne L, Bahrami Armita, Williams P Mickey, Lih Chih-Jian, Conley Barbara A, Khan Jav |
|
RASA1 and NF1 are preferentially co-mutated and define a distinct genetic subset of smoking-associated non-small cell lung carcinomas sensitive to MEK inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Nov . Hayashi Takuo, Desmeules Patrice, Smith Roger S, Drilon Alexander, Somwar Romel, Ladanyi Ma |
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
|
Sexual dimorphism in glioma glycolysis underlies sex differences in survival.
JCI insight 2017 Aug 2 (15): . Ippolito Joseph E, Yim Aldrin Kay-Yuen, Luo Jingqin, Chinnaiyan Prakash, Rubin Joshua |
|
EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas.
Cancer research 2017 Jun . Etemadmoghadam Dariush, Azar Walid J, Lei Ying, Moujaber Tania, Garsed Dale W, Kennedy Catherine, Fereday Sian, Mitchell Chris, Chiew Yoke-Eng, Hendley Joy, Group Australian Ovarian Cancer Study, Sharma Raghwa, Harnett Paul, Li Jason, Christie Elizabeth L, Patch Ann-Marie, George Joshy, Au-Yeung George, Mir Arnau Gisela, Holloway Timothy P, Semple Timothy, Pearson John V, Waddell Nicola, Grimmond Sean, Köbel Martin, Rizos Helen, Lomakin Ivan, Bowtell David D L, DeFazio An |
|
Identification of recurrent mutational events in anorectal melanoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Oct . Yang Hui Min, Hsiao Susan J, Schaeffer David F, Lai Chi, Remotti Helen E, Horst David, Mansukhani Mahesh M, Horst Basil |
|
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
Endocrine 2016 Oct . Latteyer Soeren, Tiedje Vera, König Katharina, Ting Saskia, Heukamp Lukas C, Meder Lydia, Schmid Kurt Werner, Führer Dagmar, Moeller Lars Christi |
|
Targeted next generation sequencing identifies markers of response to PD-1 blockade.
Cancer immunology research 2016 Sep . Johnson Douglas B, Frampton Garrett M, Rioth Matthew J, Yusko Erik, Xu Yaomin, Guo Xingyi, Ennis Riley C, Fabrizio David, Chalmers Zachary R, Greenbowe Joel, Ali Siraj M, Balasubramanian Sohail, Sun James X, He Yuting, Frederick Dennie T, Puzanov Igor, Balko Justin M, Cates Justin M, Ross Jeffrey S, Sanders Catherine, Robins Harlan, Shyr Yu, Miller Vincent, Stephens Philip J, Sullivan Ryan J, Sosman Jeffrey A, Lovly Christine |
|
HER2 mutations in Chinese patients with non-small cell lung cancer.
Oncotarget 2016 Aug . Song Zhengbo, Yu Xinmin, Shi Zhiyong, Zhao Jun, Zhang Yipi |
|
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer.
European urology 2016 Aug . Longo Thomas, McGinley Kathleen F, Freedman Jennifer A, Etienne Wiguins, Wu Yuan, Sibley Alexander, Owzar Kouros, Gresham Jeremy, Moy Christopher, Szabo Stephen, Greshock Joel, Zhou Hui, Bai Yuchen, Inman Brant |
|
Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
The Journal of pathology 2016 Jun . Tetzlaff Michael T, Singh Rajesh R, Seviour Elena G, Curry Jonathan L, Hudgens Courtney W, Bell Diana, Wimmer Daniel A, Ning Jing, Czerniak Bogdan A, Zhang Li, Davies Michael A, Prieto Victor G, Broaddus Russell R, Ram Prahlad, Luthra Rajyalakshmi, Esmaeli Bi |
|
Intersections at the crossroads: Neurofibromatosis type 1, cAMP, sex, and glioma risk.
Molecular & cellular oncology 2016 May 3 (3): e1069917. Rubin Joshua |
|
Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Apr . Dalin Martin G, Desrichard Alexis, Katabi Nora, Makarov Vladimir, Walsh Logan A, Lee Ken-Wing, Wang Qingguo, Armenia Joshua, West Lyndsay, Dogan Snjezana, Wang Lu, Ramaswami Deepa, Ho Alan L, Ganly Ian, Solit David, Berger Michael F, Schultz Nikolaus, Reis-Filho Jorge S, Chan Timothy A, Morris Luc |
|
Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom 2-gene targeted next-generation sequencing panel with therapeutic intent.
Gastrointestinal endoscopy 2016 Apr . Gleeson Ferga C, Kerr Sarah E, Kipp Benjamin R, Voss Jesse S, Minot Douglas M, Tu Zheng Jin, Henry Michael R, Vasmatzis George, Cheville John C, Lazaridis Konstantinos N, Levy Michael |
|
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Gynecologic oncology 2016 Apr 141 (1): 43-8. Myers Andrea P, Filiaci Virginia L, Zhang Yuping, Pearl Michael, Behbakht Kian, Makker Vicky, Hanjani Parviz, Zweizig Susan, Burke James J, Downey Gordon, Leslie Kimberly K, Van Hummelen Paul, Birrer Michael J, Fleming Gini |
|
Clinical and molecular characteristics of NF1 mutant lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Redig Amanda J, Capelletti Marzia, Dahlberg Suzanne E, Sholl Lynette M, Mach Stacy L, Fontes Caitlin, Shi Yunling, Chalasani Poornima, Janne Pasi |
|
Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Journal of molecular medicine (Berlin, Germany) 2016 Feb . Er Tze-Kiong, Su Yu-Fa, Wu Chun-Chieh, Chen Chih-Chieh, Wang Jing, Hsieh Tsung-Hua, Herreros-Villanueva Marta, Chen Wan-Tzu, Chen Yi-Ting, Liu Ta-Chih, Chen Hung-Sheng, Tsai Eing-M |
|
Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors.
Cancer genetics 2016 Jan . Mukherjee S, Ma Z, Wheeler S, Sathanoori M, Coldren C, Prescott J L, Kozyr N, Bouzyk M, Correll M, Ho H, Chandra P K, Lennon P |
|
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing.
European journal of human genetics : EJHG 2016 11 24 (11): 1591-1597. Byers Helen, Wallis Yvonne, van Veen Elke M, Lalloo Fiona, Reay Kim, Smith Philip, Wallace Andrew J, Bowers Naomi, Newman William G, Evans D Gare |
|
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
Cancer research 2015 Dec . Wong Stephen Q, Waldeck Kelly, Vergara Ismael A, Schröder Jan, Madore Jason, Wilmott James S, Colebatch Andrew J, De Paoli-Iseppi Ricardo, Li Jason, Lupat Richard, Semple Timothy, Arnau Gisela Mir, Fellowes Andrew, Leonard J Helen, Hruby George, Mann Graham J, Thompson John F, Cullinane Carleen, Johnston Meredith, Shackleton Mark, Sandhu Shahneen, Bowtell David D L, Johnstone Ricky W, Fox Stephen B, McArthur Grant A, Papenfuss Anthony T, Scolyer Richard A, Gill Anthony J, Hicks Rodney J, Tothill Richard |
|
Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
Human pathology 2015 Sep 46 (9): 1323-30. Vizcaíno M Adelita, Shah Smit, Eberhart Charles G, Rodriguez Fausto |
|
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
Molecular cancer research : MCR 2015 Apr 13 (4): 613-9. Cani Andi K, Hovelson Daniel H, McDaniel Andrew S, Sadis Seth, Haller Michaela J, Yadati Venkata, Amin Anmol M, Bratley Jarred, Bandla Santhoshi, Williams Paul D, Rhodes Kate, Liu Chia-Jen, Quist Michael J, Rhodes Daniel R, Grasso Catherine S, Kleer Celina G, Tomlins Scott |
|
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.
International journal of endocrinology 2015 2015 138573. Luchetti Andrea, Walsh Diana, Rodger Fay, Clark Graeme, Martin Tom, Irving Richard, Sanna Mario, Yao Masahiro, Robledo Mercedes, Neumann Hartmut P H, Woodward Emma R, Latif Farida, Abbs Stephen, Martin Howard, Maher Eamonn |
|
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Human pathology 2014 Aug 45 (8): 1563-71. Jour George, Scarborough John D, Jones Robin L, Loggers Elizabeth, Pollack Seth M, Pritchard Colin C, Hoch Benjamin |
|
A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Molecular cancer therapeutics 2014 Jul 13 (7): 1918-28. Xia Junfeng, Jia Peilin, Hutchinson Katherine E, Dahlman Kimberly B, Johnson Douglas, Sosman Jeffrey, Pao William, Zhao Zhongmi |
|
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
The oncologist 2014 May 19 (5): 453-8. Vasan Neil, Yelensky Roman, Wang Kai, Moulder Stacy, Dzimitrowicz Hannah, Avritscher Rony, Wang Baliang, Wu Yun, Cronin Maureen T, Palmer Gary, Symmans W Fraser, Miller Vincent A, Stephens Philip, Pusztai Laj |
|
Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.
Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
|
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms.
Oncotarget 2014 May 5 (9): 2349-54. Wheler Jennifer J, Parker Barbara A, Lee Jack J, Atkins Johnique T, Janku Filip, Tsimberidou Apostolia M, Zinner Ralph, Subbiah Vivek, Fu Siqing, Schwab Richard, Moulder Stacy, Valero Vicente, Schwaederle Maria, Yelensky Roman, Miller Vincent A, Stephens M Philip J, Meric-Bernstam Funda, Kurzrock Razel |
|
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Feb 27 (2): 271-80. Ross Jeffrey S, Wang Kai, Al-Rohil Rami N, Nazeer Tipu, Sheehan Christine E, Otto Geoff A, He Jie, Palmer Gary, Yelensky Roman, Lipson Doron, Ali Siraj, Balasubramanian Sohail, Curran John A, Garcia Lazlo, Mahoney Kristen, Downing Sean R, Hawryluk Matthew, Miller Vincent A, Stephens Philip |
|
H3F3A K27M mutations in thalamic gliomas from young adult patients.
Neuro-oncology 2014 Jan 16 (1): 140-6. Aihara Koki, Mukasa Akitake, Gotoh Kengo, Saito Kuniaki, Nagae Genta, Tsuji Shingo, Tatsuno Kenji, Yamamoto Shogo, Takayanagi Shunsaku, Narita Yoshitaka, Shibui Soichiro, Aburatani Hiroyuki, Saito Nobuhi |
|
Integrated analysis of germline and somatic variants in ovarian cancer.
Nature communications 2014 5 3156. Kanchi Krishna L, Johnson Kimberly J, Lu Charles, McLellan Michael D, Leiserson Mark D M, Wendl Michael C, Zhang Qunyuan, Koboldt Daniel C, Xie Mingchao, Kandoth Cyriac, McMichael Joshua F, Wyczalkowski Matthew A, Larson David E, Schmidt Heather K, Miller Christopher A, Fulton Robert S, Spellman Paul T, Mardis Elaine R, Druley Todd E, Graubert Timothy A, Goodfellow Paul J, Raphael Benjamin J, Wilson Richard K, Ding |
|
Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Clinical endocrinology 2013 Dec 79 (6): 817-23. P?czkowska Mariola, Kowalska Aldona, Sygut Jacek, Waligórski Dariusz, Malinoc Angelica, Janaszek-Sitkowska Hanna, Prejbisz Aleksander, Januszewicz Andrzej, Neumann Hartmut P |
|
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
Nature genetics 2013 Aug 45 (8): 927-32. Jones David T W, Hutter Barbara, Jäger Natalie, Korshunov Andrey, Kool Marcel, Warnatz Hans-Jörg, Zichner Thomas, Lambert Sally R, Ryzhova Marina, Quang Dong Anh Khuong, Fontebasso Adam M, Stütz Adrian M, Hutter Sonja, Zuckermann Marc, Sturm Dominik, Gronych Jan, Lasitschka Bärbel, Schmidt Sabine, Seker-Cin Huriye, Witt Hendrik, Sultan Marc, Ralser Meryem, Northcott Paul A, Hovestadt Volker, Bender Sebastian, Pfaff Elke, Stark Sebastian, Faury Damien, Schwartzentruber Jeremy, Majewski Jacek, Weber Ursula D, Zapatka Marc, Raeder Benjamin, Schlesner Matthias, Worth Catherine L, Bartholomae Cynthia C, von Kalle Christof, Imbusch Charles D, Radomski Sylwester, Lawerenz Chris, van Sluis Peter, Koster Jan, Volckmann Richard, Versteeg Rogier, Lehrach Hans, Monoranu Camelia, Winkler Beate, Unterberg Andreas, Herold-Mende Christel, Milde Till, Kulozik Andreas E, Ebinger Martin, Schuhmann Martin U, Cho Yoon-Jae, Pomeroy Scott L, von Deimling Andreas, Witt Olaf, Taylor Michael D, Wolf Stephan, Karajannis Matthias A, Eberhart Charles G, Scheurlen Wolfram, Hasselblatt Martin, Ligon Keith L, Kieran Mark W, Korbel Jan O, Yaspo Marie-Laure, Brors Benedikt, Felsberg Jörg, Reifenberger Guido, Collins V Peter, Jabado Nada, Eils Roland, Lichter Peter, Pfister Stefan M, |
|
Malignant peripheral nerve sheath tumours in inherited disease.
Clinical sarcoma research 2012 Oct 2 (1): 1. Evans DG, Huson SM, Birch JM |
|
Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Journal of the National Cancer Institute 2011 Nov 103 (22): 1713-22. Pasmant Eric, Sabbagh Audrey, Masliah-Planchon Julien, Ortonne Nicolas, Laurendeau Ingrid, Melin Lucie, Ferkal Salah, Hernandez Lucie, Leroy Karen, Valeyrie-Allanore Laurence, Parfait Béatrice, Vidaud Dominique, Bièche Ivan, Lantieri Laurent, Wolkenstein Pierre, Vidaud Michel, |
|
Integrated genomic analyses of ovarian carcinoma.
Nature 2011 Jun 474 (7353): 609-15. Authors are not available |
|
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.
Nature genetics 2010 Mar 42 (3): 229-33. Qin Yuejuan, Yao Li, King Elizabeth E, Buddavarapu Kalyan, Lenci Romina E, Chocron E Sandra, Lechleiter James D, Sass Meghan, Aronin Neil, Schiavi Francesca, Boaretto Francesca, Opocher Giuseppe, Toledo Rodrigo A, Toledo Sergio P A, Stiles Charles, Aguiar Ricardo C T, Dahia Patricia L |
|
SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype.
Journal of medical genetics 2009 Jul 46 (7): 431-7. Spurlock G, Bennett E, Chuzhanova N, Thomas N, Jim H-Ping, Side L, Davies S, Haan E, Kerr B, Huson S M, Upadhyaya |
|
Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Annals of the New York Academy of Sciences 2006 Aug 1073 (): 138-48. Korpershoek E, Van Nederveen F H, Dannenberg H, Petri B J, Komminoth P, Perren A, Lenders J W, Verhofstad A A, De Herder W W, De Krijger R R, Dinjens W N |
- Page last reviewed:Oct 1, 2020
- Page last updated:Oct 23, 2020
- Content source: